The Dow Jones closed lower by over 1% on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
CommScope Holding
- The Trade: CommScope Holding Company, Inc. COMM Director Claudius Watts IV acquired a total of 10,000 shares an average price of $3.43. To acquire these shares, it cost around $34,264.
- What’s Happening: CommScope Holding announced it launched its SYSTIMAX Constellation edge-based platform.
- What CommScope Holding Does: CommScope Holding Co Inc is a provider of infrastructure solutions for communication, data center and entertainment networks.
LQR House
- The Trade: LQR House Inc. LQR CEO Sean Dollinger acquired a total of 86,400 shares at an average price of $1.16. The insider spent around $100,288.
- What’s Happening: LQR House reported the pricing of its initial public offering of 1,000,000 shares of common stock at a public offering price of $5.00 per share.
- What LQR Does: LQR House Inc intends to become the full-service digital marketing and brand development face of the alcoholic beverage space.
MyMD Pharmaceuticals
- The Trade: MyMD Pharmaceuticals, Inc. MYMD Chief Legal Officer Paul Rivard acquired a total of 150,000 shares at an average price of $1.11. To acquire these shares, it cost around $166,500.
- What’s Happening: The FDA accepted MyMD Pharmaceuticals' investigational new drug application for Phase 2 study of oral TNF-α inhibitor MYMD-1 in rheumatoid arthritis.
- What MyMD Pharmaceuticals Does: MyMD Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. It is developing and commercializing two therapeutic platforms.
Check This Out: Wall Street's Most Accurate Analysts Say Hold These 3 Energy Stocks Delivering High-Dividend Yields
Don’t forget to check out our premarket coverage here
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.